Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and colleagues.
Post Content
Tim Seifert delivered an impressive performance with 93 runs in the final T20I against India,…
China is currently testing an innovative uncrewed trimaran submarine that boasts an arsenal of missiles,…